Edition:
India

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

6.34USD
20 Apr 2018
Change (% chg)

$0.04 (+0.63%)
Prev Close
$6.30
Open
$6.28
Day's High
$6.43
Day's Low
$6.16
Volume
79,507
Avg. Vol
97,664
52-wk High
$9.23
52-wk Low
$1.86

Chart for

About

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including... (more)

Overall

Beta: 0.07
Market Cap(Mil.): $127.11
Shares Outstanding(Mil.): 37.61
Dividend: --
Yield (%): --

Financials

BRIEF-Amyris Inc Files For Non-Timely 10-K With U.S. SEC

* AMYRIS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2H66fh4) Further company coverage:

03 Apr 2018

BRIEF-Amyris Reports Q4 Gaap Loss Per Share $0.17

* AMYRIS REPORTS ANOTHER STRONG QUARTER WITH SOLID OPERATING PERFORMANCE AND 2017 REVENUE OF $143.4 MILLION UP 113% OVER 2016

16 Mar 2018

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris

17 Nov 2017

BRIEF-Amyris posts Q3 GAAP loss of $1.14 per share

* Amyris reports another strong quarter of product sales growth and expects strong finish for 2017

15 Nov 2017

BRIEF-Amyris files for offering of up to 26.2 mln shares of common stock by selling stockholders‍​

* Amyris Inc files for offering of up to 26.2 million shares of common stock by the selling stockholders - SEC filing ‍​ Source text: (http://bit.ly/2zaU4Od) Further company coverage:

04 Nov 2017

Earnings vs. Estimates